About this Event
Join us for an inspiring conversation with Dr. Anil Goyal, CEO and Co-founder of IMMvention Therapeutix, as he shares insights on building fruitful partnerships between university inventors, experienced management teams, investors, and industry collaborators.
Dr. Goyal will explore the critical role university inventors play in feeding and partnering with the larger innovation ecosystem, drawing from his recent success leading IMMvention to a transformative multi-year collaboration with Novo Nordisk in 2025. He'll discuss how discoveries can be developed into globally accessible therapies through strategic partnerships and effective team-building.
Drawing on over two decades of biotech leadership, $200M+ in funding raised, and $1.5B+ in pharma deals, Dr. Goyal will cover:
- How university inventors can identify and attract the right partners
- Building complementary teams that combine academic innovation with commercial expertise
- Navigating relationships with investors and industry collaborators
- Lessons from IMMvention's journey from university spinout to Novo Nordisk partnership
- Leveraging North Carolina's thriving biotech ecosystem
Whether you're a faculty researcher considering commercialization, an early-stage entrepreneur, or interested in understanding how academic innovation translates to real-world impact, this session will provide practical insights on building the partnerships that turn scientific breakthroughs into transformative therapies.
Event Venue & Nearby Stays
The Rizzo Center, 150 Dubose Home Lane, Chapel Hill, United States
USD 0.00
